Association of troponin T and altered lipid profile in patients admitted with acute myocardial infarction

Archives of Physiology and Biochemistry

Volumn 116, Issue 1, 2010, Pages 21-27

  Nayak, Shivananda B ^a   Pinto Pereira, Lexley M ^a   Boodoo, Shantal ^b   Kimberlyali, Annalise ^b   Baptiste, Cherishe ^b   Maraj, Sushain ^b   Persad, Neil ^b   Khan, Nadia ^b   Surendran, Subina ^c   Legall, George ^a  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

^b UNIVERSITY OF THE WEST INDIES   (Jamaica)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

High density lipoprotein; Lipid profile; Low density lipoprotein; Myocardial infarction; Total cholesterol; Troponin T

Indexed keywords

BIOLOGICAL MARKER; LIPID; TROPONIN T;

ADULT; AGED; ARTICLE; BLOOD; FEMALE; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; STATISTICS; TRINIDAD AND TOBAGO;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; STATISTICS AS TOPIC; TRINIDAD AND TOBAGO; TROPONIN T;

EID: 77949418527     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813450903397638     Document Type: Article

References (18)

1. Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ. (1977). HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation 55(5):767-772
2. Chia S, Senatore F, Raffel OC, Lee H, Wackers FJ, Jang IK. (2008). Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Assessing TnI72h after primary PCI is a simple, effective method to estimate infarct size, LVEF, and potentially useful for risk stratification. JACC Cardiovasc Interv. 1(4):415-423
3. De Goma E, Leeper N, Heidenreich P. (2001). Clinical significance of high-density lipoprotein cholesterol in patients with low-density lipoprotein cholesterol. J Am Coll Cardiol 51(1):49-55.
4. Francis Q, Almeda, J, Calvin E. (2002). Troponin T in acute coronary syndromes: mechanisms and management issues. Found J Am Coll Cardiol 39(8):1404-1405
5. Freedman DS, Newman WP, Tracy RE, Voors AE, Srinivasan SR, Webber LS, estrepo C, Strong JP, GS Berenson.(1988). Black-white differences in aortic fatty streaks in adolescence and early adulthood: The Bogalusa Heart Study. Circulation 77:856-864
6. Hara H, Nakamura M, Yokouchi I, Kimura K, Nemoto N, Ito S, Ono T, Shiba M, Wada M, Tsuji T, et al. (2007). Impact of statin therapy on coronary intervention for non-ST elevation acute coronary syndrome with decreased low-density lipoprotein cholesterol. J Cardiol 49(3):115-123
7. Hickman TB, Briefel RR, Carroll MD, Rifkind BM, Cleeman JI, Maurer KR, Johnson CL. (1998). Distribution and trends of serum lipid levels among United States children and adolescents ages 4-19 years: Data from the Third National Health and Nutrition Examination Survey. Prev Med 27:879-890
8. Hong MK, Romm PA, Reagan K, Green CE, Rackley CE. (1991). Usefulness of the total cholesterol to high density cholesterol ratio in predicting angiographic coronary artery disease in women. Am J Cardiol 68(17):1646-1650
9. Johnson PA, Goldman L, Sacks DB, Garcia T, Albano M, Bezai M, Pedan A, Cook EF, Lee TH. (1999). Cardiac troponin T as a marker for myocardial ischemia in patients seen at the emergency department for acute chest pain. Am Heart J 137(6):1137-1144
10. Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, Cain VA, Blasetto JW. (2003). Comparison of the efficacy and safety of Rosuvastatin versus Atorvastatin, Simvastatin and Pravastatin across doses (STELLAR Trial). Am J Cardiol 92(2):152-160
11. Kumar V, Cotran RS, Robbins SL. (2003). Basic pathology. 7th edn. Philadelphia: Saunders.
12. Lacy CF, Armstrong LL, Goldman MP, Lance LL. (2006). Lexi Comp's drug information handbook. 14th edn. Ohio: American Pharmaceutical Association, pp. 1840-1846
13. Lindquist CH, Gower BA, Goran MI. (2000). Role of dietary factors in ethnic differences in early risk of cardiovascular diseases and Type 2 Diabetes. Am J Clin Nutr: Am Soc Clin Nutr 71:725-732
14. Novak PD. (1995). Dorland's medical dictionary. 25th edn. Philadelphia: W.B Saunders Company.
15. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, Biedert S, Schaub N, Buerge C, Potocki M, et al. (2009). Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 361(9):858-867
16. Ridker PM, Stampfer MJ, Rifai N. (2001). Novel risk factors for systemic atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a) and standard cholesterol screening as predictors of peripheral arterial disease. J Am Med Assoc 285(19):2481-2485
17. Walley T, Folino-Gallo P, Schwabe U, van Ganse E. (2004). Variations and increase in use of statins across Europe: Data from administrative databases. BMJ 328:385-386
18. Wendy Lim, Qushmaq I, Deborah JC, Mark AC, Diane HA, Devereaux PJ. (2005). Elevated troponin and myocardial infarction in the intensive care unit: a prospective study. Crit Care 9:R636-R644.